SCHEMBL30989366

SCHEMBL30989366

COc1nccc(F)c1CCl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AURKA O14965 1/20 0.33
TTK P33981 1/20 0.33
AURKB Q96GD4 1/20 0.33
INCENP Q9NQS7 1/20 0.33
STING1 Q86WV6 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
APLNR P35414 1/20 0.31
CHRNB4 P30926 2/20 0.31
CHRNA3 P32297 2/20 0.31
CCR1 P32246 1/20 0.31
CCR5 P51681 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25650131 0.81 STING1 (0.34) TRPA1KMT2AALDH1A1ATML3MBTL1
SCHEMBL31038852 0.81 LOXL2 (0.41) TRPA1AURKATTKAURKBINCENP
SCHEMBL31214403 0.79 MAPK1 (0.39) TRPA1KMT2AALDH1A1L3MBTL1AURKA
SCHEMBL31151108 0.79 NOS2 (0.40) ALDH1A1AURKATTKAURKBINCENP
SCHEMBL27047601 0.79 PDCD1 (0.35) TRPA1KMT2AALDH1A1AURKATTK
SCHEMBL4405916 0.78 AURKA (0.33) AURKATTKAURKBINCENPAPLNR
SCHEMBL27882381 0.76 TRPA1 (0.39) TRPA1KMT2AALDH1A1AURKATTK
SCHEMBL29517451 0.76 TRPA1 (0.39) TRPA1KMT2AALDH1A1AURKATTK
SCHEMBL21598410 0.75 CCR4 (0.37) TRPA1KMT2AL3MBTL1AURKATTK
SCHEMBL25270718 0.74 LRRK2 (0.33) TRPA1KMT2AALDH1A1ATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118359638-A Compound serving as RET kinase inhibitor and preparation method and application thereof 苏州朗睿生物医药有限公司 2024-07-19 CN disclosed